Abstract:Reduced interest in typically rewarding activities is implicated in opioid use disorder. In male rats, acute morphine withdrawal results in decreased motivation for food rewards and compromised flexibility in goal‐directed behaviour, despite intact hedonic processing of reward. Following prolonged withdrawal, rats exhibit heightened motivation for food rewards but impaired motivation and goal‐directed action selection upon re‐exposure to morphine. These findings underscore how opioid withdrawal‐induced deficits in motivation and goal‐directed control may impede the pursuit of adaptive behavioural alternatives, potentially contributing to addiction. Opioid addiction is a relapsing disorder marked by uncontrolled drug use and reduced interest in normally rewarding activities. The current study investigated the impact of spontaneous withdrawal from chronic morphine exposure on emotional, motivational and cognitive processes involved in regulating the pursuit and consumption of food rewards in male rats. In Experiment 1, rats experiencing acute morphine withdrawal lost weight and displayed somatic signs of drug dependence. However, hedonically driven sucrose consumption was significantly elevated, suggesting intact and potentially heightened reward processing. In Experiment 2, rats undergoing acute morphine withdrawal displayed reduced motivation when performing an effortful response for palatable food reward. Subsequent reward devaluation testing revealed that acute withdrawal disrupted their ability to exert flexible goal‐directed control over reward seeking. Specifically, morphine‐withdrawn rats were impaired in using current reward value to select actions both when relying on prior action‐outcome learning and when given direct feedback about the consequences of their actions. In Experiment 3, rats tested after prolonged morphine withdrawal displayed heightened rather than diminished motivation for food rewards and retained their ability to engage in flexible goal‐directed action selection. However, brief re‐exposure to morphine was sufficient to impair motivation and disrupt goal‐directed action selection, though in this case, rats were only impaired in using reward value to select actions in the presence of morphine‐paired context cues and in the absence of response‐contingent feedback. We suggest that these opioid‐withdrawal induced deficits in motivation and goal‐directed control may contribute to addiction by interfering with the pursuit of adaptive alternatives to drug use.

VTA μ-opioidergic neurons facilitate low sociability in protracted opioid withdrawal

Striatal μ-opioid receptor activation triggers direct-pathway GABAergic plasticity and induces negative affect

CRHCeA→VTA inputs inhibit the positive ensembles to induce negative effect of opiate withdrawal

Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice

Blockade of orexin receptor 1 attenuates morphine protracted abstinence-induced anxiety-like behaviors in male mice

Opioid withdrawal: role in addiction and neural mechanisms

The Basolateral Amygdala to Ventral Hippocampus Circuit Controls Anxiety-like Behaviors Induced by Morphine Withdrawal

Targeting mitochondrial dynamics of morphine-responsive dopaminergic neurons ameliorates opiate withdrawal

Mu-Opioid Receptors Expressed in Glutamatergic Neurons Are Essential for Morphine Withdrawal.

Differential effects of acute and prolonged morphine withdrawal on motivational and goal‐directed control over reward‐seeking behaviour

Mesoaccumbens Dopamine Signaling Alteration Underlies Behavioral Transition from Tolerance to Sensitization to Morphine Rewarding Properties During Morphine Withdrawal

Parvalbumin Interneurons of Central Amygdala Regulate the Negative Affective States and the Expression of Corticotrophin-Releasing Hormone During Morphine Withdrawal.

Rostral and Caudal Ventral Tegmental Area GABAergic Inputs to Different Dorsal Raphe Neurons Participate in Opioid Dependence

Opioid Withdrawal Abruptly Disrupts Amygdala Circuit Function by Reducing Peptide Actions

Ionotropic Glutamatergic Neurotransmission in the Ventral Tegmental Area Modulates ΔFosB Expression in the Nucleus Accumbens and Abstinence Syndrome in Morphine Withdrawal Rats

Opioid-driven disruption of the septal complex reveals a role for neurotensin-expressing neurons in withdrawal

Amygdalar κ-opioid receptor-dependent upregulating glutamate transporter 1 mediates depressive-like behaviors of opioid abstinence

Circadian Alteration in Neurobiology During Protracted Opiate Withdrawal

A master regulator of opioid reward in the ventral prefrontal cortex

Corticotrophin-releasing hormone neurons in the central amygdala mediate morphine withdrawal-induced negative emotions

Nucleus accumbens D1/D2 circuits control opioid withdrawal symptoms in mice